DK0941241T3 - Bordetella-stamme, som udtrykker hybridet FHA - Google Patents

Bordetella-stamme, som udtrykker hybridet FHA

Info

Publication number
DK0941241T3
DK0941241T3 DK97944948T DK97944948T DK0941241T3 DK 0941241 T3 DK0941241 T3 DK 0941241T3 DK 97944948 T DK97944948 T DK 97944948T DK 97944948 T DK97944948 T DK 97944948T DK 0941241 T3 DK0941241 T3 DK 0941241T3
Authority
DK
Denmark
Prior art keywords
fha
protein
hybrid
toxin
bordetella strain
Prior art date
Application number
DK97944948T
Other languages
English (en)
Inventor
Gilles Riveau
Odile Poulain-Godefroy
Nathalie Mielcarek
Camille Locht
Andre Capron
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of DK0941241T3 publication Critical patent/DK0941241T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Aiming, Guidance, Guns With A Light Source, Armor, Camouflage, And Targets (AREA)
DK97944948T 1996-10-11 1997-10-09 Bordetella-stamme, som udtrykker hybridet FHA DK0941241T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9612461A FR2754543B1 (fr) 1996-10-11 1996-10-11 Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
PCT/FR1997/001802 WO1998016553A1 (fr) 1996-10-11 1997-10-09 Souche de bordetella exprimant de la fha hybride, liposomes et vaccins

Publications (1)

Publication Number Publication Date
DK0941241T3 true DK0941241T3 (da) 2008-11-17

Family

ID=9496598

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97944948T DK0941241T3 (da) 1996-10-11 1997-10-09 Bordetella-stamme, som udtrykker hybridet FHA

Country Status (12)

Country Link
US (1) US6660261B1 (da)
EP (1) EP0941241B1 (da)
JP (1) JP4370541B2 (da)
AT (1) ATE403675T1 (da)
AU (1) AU725137B2 (da)
CA (1) CA2267851C (da)
DE (1) DE69738888D1 (da)
DK (1) DK0941241T3 (da)
ES (1) ES2309998T3 (da)
FR (1) FR2754543B1 (da)
PT (1) PT941241E (da)
WO (1) WO1998016553A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29082A (id) * 1998-09-22 2001-07-26 Molecular Express Inc Komposisi liposom imunogenik
FR2840319B1 (fr) * 2002-05-30 2004-08-20 Pasteur Institut Souches de bordetella rendues deficientes par attenuation genetique
ES2821830T3 (es) 2006-03-10 2021-04-27 Pasteur Institut Cepas de Bordetella vivas atenuadas como vacuna de dosis única contra la tos ferina
CA2759280C (en) 2009-04-28 2016-09-20 Inserm (Institut National De La Sante Et De La Recherche Medicale) Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
EP2442826B1 (en) 2009-06-15 2015-07-08 National University of Singapore Influenza vaccine, composition, and methods of use
CN104302314B (zh) 2011-11-02 2020-06-02 新加坡国立大学 减毒博代氏杆菌菌株对抗变应性疾病的效果
EP2722338A1 (en) 2012-10-17 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel recombinant Bordetella strains
US9655959B2 (en) 2014-10-01 2017-05-23 National University Of Singapore Adenylate cyclase deficient bordetella strains
DK3436034T3 (da) * 2016-03-29 2025-05-12 Pasteur Institut Muterede bordetella-stammer og fremgangsmåder til brug
WO2019077028A1 (en) * 2017-10-18 2019-04-25 Institut Pasteur De Lille BORDETELLA STRAINS EXPRESSING SERO-TYPE FIMBRIAE 3

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571078B2 (en) * 1984-04-14 1988-03-31 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Purification of filamentous hemagglutinin
FR2590483B1 (fr) * 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
WO1989001976A1 (en) * 1987-09-04 1989-03-09 Amgen Inc. Recombinant dna-derived bordetella toxin subunit analogs
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
DD268161A1 (de) * 1987-11-27 1989-05-24 Staatliches Inst Fuer Immunpra Verfahren zur herstellung von bakteriellen antigenen
US6036960A (en) * 1988-10-27 2000-03-14 Relman; David A. Filamentous hemagglutinin of B. pertussis
ATE127347T1 (de) * 1989-04-28 1995-09-15 Sclavo Spa Pertussistoxin-mutanten, dieselbe produzierende bordetella-stämme und ihre verwendung als vakzin gegen pertussis.
GB8910570D0 (en) * 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
EP0471954A3 (en) * 1990-08-13 1993-03-03 American Cyanamid Company Immunogenic conjugates of nontoxic oligosaccharide derived from bordetella pertussis lipooligosaccharide
NL9002092A (nl) * 1990-09-25 1992-04-16 Nederlanden Staat Vaccin, geschikt voor de bestrijding van bordetella pertussis.
FR2718750B1 (fr) * 1994-04-19 1996-06-14 Pasteur Institut Protéines recombinantes de l'hémagglutinine filamenteuse de Bordetella, notamment, B. Pertussis, production et application à la production de protéines étrangères ou de principes actifs vaccinants.
US7532327B2 (en) * 2004-09-17 2009-05-12 Jmar Research, Inc. Systems and methods for detecting scattered light from a particle using illumination incident at an angle

Also Published As

Publication number Publication date
DE69738888D1 (de) 2008-09-18
US6660261B1 (en) 2003-12-09
PT941241E (pt) 2008-10-23
AU725137B2 (en) 2000-10-05
EP0941241A1 (fr) 1999-09-15
FR2754543B1 (fr) 1998-12-31
CA2267851C (fr) 2011-12-13
ES2309998T3 (es) 2008-12-16
FR2754543A1 (fr) 1998-04-17
JP4370541B2 (ja) 2009-11-25
ATE403675T1 (de) 2008-08-15
JP2001507568A (ja) 2001-06-12
CA2267851A1 (fr) 1998-04-23
WO1998016553A1 (fr) 1998-04-23
AU4627897A (en) 1998-05-11
EP0941241B1 (fr) 2008-08-06

Similar Documents

Publication Publication Date Title
NO177269C (no) Autonome replikasjonssekvenser (PARS) for gjærarter av slekten Pichia og plasmid inneholdende disse
BG101384A (en) New pesticide proteins and strains
NO950534L (no) Modufiserte soppceller og fremgangsmåter for fremstilling av rekombinante produkter
NO331271B1 (no) Fusjonsprotein for sekresjon av et protein av interesse til supernatanten til en bakteriekultur, fremgangsmate, plasmid og vertscelle for fremstilling
DE69734936D1 (de) Wirtszellen und methoden für die produktion von proteinen
DK0941241T3 (da) Bordetella-stamme, som udtrykker hybridet FHA
DK0892054T3 (da) Clostridium perfringens-vaccine
AR016680A2 (es) Novedosas toxinas pesticidas y secuencias de polinucleotidos que codifican estas toxinas
GB9409985D0 (en) Vaccine against mycobacterial infections
PT574347E (pt) Nova protease fungica
DE69532122D1 (de) Erhöhte produktion von beta-galaktosidase in aspergillus oryzae
AU3162097A (en) Retinoid metabolizing protein
AUPM772494A0 (en) Improvements in production of proteins in host cells
SI1127943T1 (sl) Sredstva in postopki za ekspresijo homolognih in heterolognih proteinov v sevih Rhodococcus
AU1321988A (en) The cloning of malaria-specific dna sequences: isolation of the gene for the 140 kd protein
ATE292683T1 (de) Erhöhung der proteinproduktion in gram-positiven mikroorganismen
AU6358096A (en) New immunoregulatory protein lst-1
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.
DE69532109D1 (de) Expression heterologer proteine in abgeschwächten bakterien mittels des htra-promotors
ATE341613T1 (de) Fluordesoxyuridin-resistente streptococcus gordonii stämme